Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check5 days agoChange DetectedA new revision tag v3.7.0 has been added, replacing the previous v3.6.6, indicating the page was updated to a newer software/version release.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study history introduces a Results Posted entry and adds Outcome Measures (Results) and related Study Status updates, while removing the previous Results Submitted entry from 2024-07-09, reflecting that results are now available on the record.SummaryDifference1%

- Check20 days agoChange DetectedThe most recent version adds sections for Outcome Measures (Results), Document Section, Outcome Measures, and Study Status, and notes that the Quality Control Review Has Not Concluded. This indicates the latest submission includes results-related content and shows a pending QC status for the record.SummaryDifference0.6%

- Check27 days agoChange DetectedA new version entry (22) dated 2026-08-24 is added to the study record history, introducing multiple expanded sections such as Returned, Quality Control Review Has Not Concluded, Limitations and Caveats, and Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Design. The update also notes Revision: v3.6.6 and removes Revision: v3.6.5, reflecting an update to the record's documentation and structure.SummaryDifference1%

- Check48 days agoChange DetectedA new revision entry v3.6.5 is added to the study's version history, and the previous revision v3.6.4 is removed from the visible history to update the audit trail.SummaryDifference0.1%

- Check55 days agoChange DetectedThe latest version shows major study-data sections and QC status, along with the Returned date. This reflects the addition of structured data areas in the record history.SummaryDifference1%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.